rs120074193
Variant summary
The NM_000218.3(KCNQ1):c.805G>A (p.Gly269Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a cumulative frequency of 0.0000198 (AC=29) in the gnomAD database across 1,461,454 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000653. Note: a gnomAD entry for this variant shows a statistical allele-bias signature, consistent with mosaic/somatic contamination (e.g. age-related clonal hematopoiesis) rather than true inherited population frequency — this frequency should not be read as evidence of a common, benign germline variant. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 9.42). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV005399103: "This variant has moderate functional evidence supporting abnormal protein function. In vitro studies show that this variant has abnormal delayed rectifier potassium current, defects in subcellular localisation, reduced stability, and a dominant negative effect over wild type (PMID:20044973, 24184248)."" and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.G269V: Pathogenic (ClinVar VariationId 200899, 1 star) This exact variant is curated in the UniProt human variants database as Pathogenic, associated with Long qt syndrome 1 (lqt1).
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Jervell and Lange-Nielsen syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Jervell and Lange-Nielsen syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- long QT syndrome 1Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- atrial fibrillation, familial, 3Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- short QT syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
- short QT syndrome type 2Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Jervell and Lange-Nielsen syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- familial hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: G2P
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 17 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV005399103: "This variant has moderate functional evidence supporting abnormal protein function. In vitro studies show that this variant has abnormal delayed rectifier potassium current, defects in subcellular localisation, reduced stability, and a dominant negative effect over wild type (PMID: 20044973, 24184248)."; SCV005440608: "Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product."; SCV000234421: Published functional studies demonstrate a damaging effect as this variant may cause abnormal assembly and stability of the potassium channel and exert moderate dominant-negative suppression of the potassium channel (Verma et al., 2009; Wu et al., 2014; Wang et al., 2014); SCV000543295: Experimental studies have shown that this missense change affects KCNQ1 function (PMID: 20044973, 24184248).; SCV005426308: A functional study has shown that this variant leads to a modest reduction in potassium channel current under control conditions and results in a completely blunted channel response to PKA stimulation (PMID: 24184248).; SCV001160534: "functional studies demonstrate that the p.Gly269Ser variant causes a reduction in potassium ion current and protein stability (Wu 2014 and Verma 2010)."; SCV002675873: "In multiple assays testing KCNQ1 function, this variant showed functionally abnormal results (Murray A et al. J. Med. Genet., 2002 Sep;39:681-5; Wu J et al. J. Am. Coll. Cardiol., 2014 Mar;63:819-27)."; SCV006064784: A functional study has shown that this variant leads to a modest reduction in potassium channel current under control conditions and results in a completely blunted channel response to PKA stimulation (PMID: 24184248). | ||
| PM1Mutational hot spot or critical domain | Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 23 pathogenic, 1 benign (OR vs. background: 78.3). | ||
| PM2Absent/extremely low in population databases | Rare in gnomAD for AD/XL gene (popmax AF below threshold) — PM2 Supporting; GnomAD popmax AF = 0.0000653 — borderline rare for AD+AR gene (base 0.0001, raised to 0.00022 by highest known P/LP ClinVar AF 0.00022) — PM2 supporting. | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.G269V: Pathogenic (ClinVar VariationId 200899, 1 star) | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — strong evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Strong). | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (14/14 total P/LP). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000218.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
KCNQ1 | MANE Select | c.805G>A p.Gly269Ser | missense | Exon 6 of 16 | Prot: NP_000209.2 | |
KCNQ1 | c.805G>A p.Gly269Ser | missense | Exon 6 of 15 | Prot: NP_001393765.1 | ||
KCNQ1 | c.535G>A p.Gly179Ser | missense | Exon 7 of 17 | Prot: NP_001393766.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
KCNQ1 | TSL:1MANE Select | c.805G>A p.Gly269Ser | missense | Exon 6 of 16 | Prot: ENSP00000155840.2 UniProt: | |
KCNQ1 | TSL:1 | c.424G>A p.Gly142Ser | missense | Exon 6 of 16 | Prot: ENSP00000334497.5 UniProt: | |
KCNQ1 | c.802G>A p.Gly268Ser | missense | Exon 6 of 16 | Prot: ENSP00000581056.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.00000657 | AC:1 | Hom:0 | AN:152238 | Cov:33 |
GnomAD2 exomes | AF: 0.00000399 | AC:1 | AN:250528 | ||
GnomAD4 exome | AF: 0.0000198 | AC:29 | Hom:0 | AN:1461454 | Cov:32 |
GnomAD4 genome | AF: 0.00000656 | AC:1 | Hom:0 | AN:152356 | Cov:33 |
TOPMed (Bravo) | AF: 0.00000378 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000185 | AC:4 | Hom:0 | AN:216362 | |
Local & regional cohorts 2 sources | |||||
ABraOM SABE-WGS-1171 | AF: 0.000427 | AC:1 | Hom:0 | AN:2342 | |
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.0000160 | AC:2 | Hom:0 | AN:122504 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
BipEx | 0.0000352 | 1 | 28420 | 0.0000347 | 1 | 28844 |
Epi25 | 0.00 | 0 | 41958 | 0.0000150 | 1 | 66888 |
SCHEMA | 0.00000970 | 1 | 103044 | 0.0000163 | 3 | 184104 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 29 | |
AlphaMissense | Pathogenic | 0.93 | |
BayesDel_addAF | Pathogenic | 0.49 | D |
BayesDel_noAF | Pathogenic | 0.54 | |
CADD | Pathogenic | 33 | |
CardioboostArm | Pathogenic | 1.0 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Pathogenic | 0.98 | D |
Eigen | Uncertain | 0.49 | |
Eigen_PC | Uncertain | 0.43 | |
FATHMM_MKL | Uncertain | 0.97 | D |
FuncVEP CTI | Pathogenic | 1.0 | |
GPN-Star LLR | N/A | -9.8 | |
GPN-Star score | N/A | 9.8 | |
LIST_S2 | Pathogenic | 0.99 | D |
M_CAP | Pathogenic | 0.91 | D |
MetaRNN | Pathogenic | 0.97 | D |
MetaSVM | Pathogenic | 1.1 | D |
Mutation Taster | N/A | 0/100 | disease causing (ClinVar) |
MutationAssessor | Benign | 1.4 | L |
PhyloP100 | Pathogenic | 9.4 | |
popEVE | Benign | -3.5 | |
PrimateAI | Pathogenic | 0.85 | D |
PROVEAN | Pathogenic | -5.9 | D |
REVEL | Pathogenic | 0.93 | |
Sift | Benign | 0.070 | T |
Sift4G | Benign | 0.075 | T |
Varity_R | N/A | 0.97 | |
VESM-3B | Benign | -11 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.030 | |
SpliceAI score (max) | Benign | 0.070 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.